Press Releases

08.14.2015

Pfizer Granted Approval From The Canadian Competition Bureau For Hospira Acquisition

08.13.2015

HiFiBiO SAS Achieves Milestone in Antibody Research Collaboration with Pfizer Inc.

08.13.2015

Pfizer Receives Approval from the Australian Competition and Consumer Commission for Pending Acquisition of Hospira

08.04.2015

Pfizer Receives Approval From European Commission For Pending Acquisition Of Hospira

08.03.2015

Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis

07.28.2015

PFIZER REPORTS SECOND-QUARTER 2015 RESULTS

07.22.2015

Pfizer Announces Expansion of Lease Agreement with Massachusetts Institute of Technology Subsidiary for Kendall Square Research Facility

07.08.2015

Pfizer’s Centers For Therapeutic Innovation And Jeffrey Modell Foundation Announce Collaboration to Help Advance Immunological Research

07.07.2015

Pfizer Begins Phase 2b Study Of Its Investigational Multi-antigen Staphylococcus aureus Vaccine In Adults Undergoing Elective Spinal Fusion Surgery

07.02.2015

Pfizer Announces FDA Acceptance for Review of New Drug Application for A Once-Daily Formulation of XELJANZ® (tofacitinib citrate) Modified Release Tablets

06.25.2015

Joseph J. Echevarria Elected To Pfizer’s Board Of Directors

06.25.2015

Pfizer Declares 28-Cent Third-Quarter 2015 Dividend